border left blue header line border right
INBRE logo header text
header bottom
  External Advisory Committee  

James W. Hardin, Ph.D.

SunEco Energy

James Hardin is a molecular biologist by training with a Ph.D. from Purdue University and postdoctoral training at Harvard University. He spent 25 years as a faculty member at Baylor College of Medicine - University of Arkansas for medical sciences and Saint Louis University. He was COO/Executive Vice President of the John Wayne Cancer Center where he oversaw a staff of 200. He was CEO of Mitos Pharmaceutical and has reviewed and made funding decisions on over 50 biotechnology companies. He has testified before national and state legislative committees.

Dr. Hardin has also led and participated in numerous NCI cancer center accreditation site visits and has an extensive research and science background. He has held faculty appointments in the Department of Cell Biology at Baylor College of Medicine and in the Departments of Biochemistry, Medicine,  and Pathology at the University of Arkansas for Medical Sciences from 1976 to 1998.

 Dr. Hardin has received several honors, written numerous manuscripts and book chapters, and serves on external review panels for the National Institutes of Health, National Science Foundation, United States Department of Agriculture, and American Cancer Society.

 He has also had extensive experience in biotechnology, serving as chairman of the University of Arkansas for Medical Sciences (UAMS) patent committee and as a founding director of the V.A. Biomedical and Research Foundation. He also developed the UAMS patent policy, scientific fraud policy, and conflict of interest policy.


Updated 10/14/2015


The Arkansas INBRE is supported by a grant  from the National Institutes of Health

National Institute of General Medical Sciences (P20 GM103429).

Please contact Diane McKinstry regarding questions or comments about this site or our program.
For more information about the University of Arkansas for Medical Sciences visit

  blue footer line